Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Epirus Biopharmaceuticals Inc    

EPIRUS BIOPHARMACEUTICALS INC
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancials 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Company
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business.It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference... 
More about the company
Latest news on EPIRUS BIOPHARMACEUTICALS
2016EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars ..
GL
2016EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financi..
GL
2016EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Fina..
GL
2016EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for..
GL
2016EPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare..
GL
2016J&J, AbbVie Shares Drop on Potential Drug Competition
DJ
2016EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global He..
GL
2015EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Inflixi..
GL
2015EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Prov..
GL
2015EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Result..
GL
More news
Sector news : Biotechnology & Medical Research - NEC
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
06/20Roche to Buy Rest of Cancer Firm -- WSJ
DJ
06/20Latecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/19Roche to Pay $2.4 Billion for Full Control of Foundation Medicine -- 2nd Upda..
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart EPIRUS BIOPHARMACEUTICALS
Duration : Period :
Epirus Biopharmaceuticals  Technical Analysis Chart | US29428P1075 | 4-Traders
Income Statement Evolution
Sector and Competitors
1st jan.Capitalization (M$)
EPIRUS BIOPHARMACEUTICALS INC7.14%0
CELLTRION, INC.--.--%33 349
IQVIA HOLDINGS INC6.07%21 424
LONZA GROUP3.53%20 530
INCYTE CORPORATION-22.94%15 692
SEATTLE GENETICS, INC.24.95%10 577